Skip to main content
Other
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)
Pharmacy Faculty Research
  • Jeffrey L. Huston, Cedarville University
Role

Lead Pharmacist

Date
1-1-2006
Location
Dallas, TX
Citation Information
Jeffrey L. Huston. "A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Dose of CBR-2092 in Healthy Volunteers (CBR-2092-001)" (2006)
Available at: http://works.bepress.com/jeffrey_huston/3/